AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: BUDMAN DR MEROPOL NJ REIGNER B CREAVEN PJ LICHTMAN SM BERGHORN E BEHR J GORDON RJ OSTERWALDER B GRIFFIN T
Citation: Dr. Budman et al., PRELIMINARY STUDIES OF A NOVEL ORAL FLUOROPYRIMIDINE CARBAMATE - CAPECITABINE, Journal of clinical oncology, 16(5), 1998, pp. 1795-1802

Authors: CREAVEN PJ PENDYALA L MEROPOL NJ CLENDENINN NJ WU EY LOEWEN GM PROEFROCK A JOHNSTON A DIXON M
Citation: Pj. Creaven et al., INITIAL CLINICAL-TRIAL AND PHARMACOKINETICS OF THYMITAQ(TM) (AG337) BY 10-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 167-170

Authors: MEROPOL NJ BLUMENSON LE CREAVEN PJ
Citation: Nj. Meropol et al., OCTREOTIDE DOES NOT PREVENT DIARRHEA IN PATIENTS TREATED WITH WEEKLY 5-FLUOROURACIL PLUS HIGH-DOSE LEUCOVORIN, American journal of clinical oncology, 21(2), 1998, pp. 135-138

Authors: PENDYALA L VELAGAPUDI S TOTH K ZDANOWICZ J GLAVES D SLOCUM H PEREZ R HUBEN R CREAVEN PJ RAGHAVAN D
Citation: L. Pendyala et al., TRANSLATIONAL STUDIES OF GLUTATHIONE IN BLADDER-CANCER CELL-LINES ANDHUMAN SPECIMENS, Clinical cancer research, 3(5), 1997, pp. 793-798

Authors: SONI N MEROPOL NJ PENDYALA L NOEL D SCHACTER LP GUNTON KE CREAVEN PJ
Citation: N. Soni et al., PHASE-I AND PHARMACOKINETIC STUDY OF ETOPOSIDE PHOSPHATE BY PROTRACTED VENOUS INFUSION IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 15(2), 1997, pp. 766-772

Authors: CREAVEN PJ PEREZ R PENDYALA L MEROPOL NJ LOEWEN G LEVINE E BERGHORN E RAGHAVAN D
Citation: Pj. Creaven et al., UNUSUAL CENTRAL-NERVOUS-SYSTEM TOXICITY IN A PHASE-I STUDY OF N(1)N(11)DIETHYLNORSPERMINE IN PATIENTS WITH ADVANCED MALIGNANCY, Investigational new drugs, 15(3), 1997, pp. 227-234

Authors: CREAVEN PJ RAGHAVAN D PENDYALA L LOEWEN G KINDLER HL BERGHORN EJ
Citation: Pj. Creaven et al., PACLITAXEL AND CARBOPLATIN IN EARLY PHASE STUDIES - ROSWELL-PARK-CANCER-INSTITUTE EXPERIENCE IN THE SUBSET OF PATIENTS WITH LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 138-143

Authors: MEROPOL NJ PORTER M BLUMENSON LE LINDEMANN MJ PEREZ RP VAICKUS L LOEWEN GM CREAVEN PJ WILKES KA GIEDLIN MA CALIGIURI MA
Citation: Nj. Meropol et al., DAILY SUBCUTANEOUS INJECTION OF LOW-DOSE INTERLEUKIN-2 EXPANDS NATURAL-KILLER-CELLS IN-VIVO WITHOUT SIGNIFICANT TOXICITY, Clinical cancer research, 2(4), 1996, pp. 669-677

Authors: ELAKAWI Z ZDANOWICZ J CREAVEN PJ ABUHADID M PEREZ R PENDYALA L
Citation: Z. Elakawi et al., INDUCTION OF GAMMA-GLUTAMYL-TRANSPEPTIDASE MESSENGER-RNA BY PLATINUM COMPLEXES IN A HUMAN OVARIAN-CARCINOMA CELL-LINE, Oncology research, 8(10-11), 1996, pp. 415-423

Authors: MEROPOL NJ RUSTUM YM PETRELLI NJ RODRIGUEZBIGAS M FRANK C HO DH KUROWSKI M CREAVEN PJ
Citation: Nj. Meropol et al., A PHASE-I AND PHARMACOKINETIC STUDY OF ORAL URACIL, FTORAFUR, AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 581-586

Authors: ELAKAWI Z ABUHADID M PEREZ R GLAVY J ZDANOWICZ J CREAVEN PJ PENDYALA L
Citation: Z. Elakawi et al., ALTERED GLUTATHIONE METABOLISM IN OXALIPLATIN RESISTANT OVARIAN-CARCINOMA CELLS, Cancer letters, 105(1), 1996, pp. 5-14

Authors: CREAVEN PJ RAGHAVAN D PEREZ RP PENDYALA L BERGHORN EJ LOEWEN G MEROPOL NJ
Citation: Pj. Creaven et al., EARLY PHASE STUDIES WITH PACLITAXEL LOW-DOSE CARBOPLATIN IN PATIENTS WITH SOLID TUMORS/, Seminars in oncology, 23(6), 1996, pp. 26-31

Authors: COOGAN MM CREAVEN PJ MACKOWN JM GALPIN JS
Citation: Mm. Coogan et al., AN IMPRESSION TECHNIQUE AND CONVENTIONAL TESTS FOR PREDICTING CARIES ACTIVITY, Journal of dental research, 75(5), 1996, pp. 1307-1307

Authors: MEROPOL NJ CREAVEN PJ PETRELLI NJ WHITE RM ARBUCK SG
Citation: Nj. Meropol et al., SEIZURES ASSOCIATED WITH LEUCOVORIN ADMINISTRATION IN CANCER-PATIENTS, Journal of the National Cancer Institute, 87(1), 1995, pp. 56-58

Authors: PENDYALA L CREAVEN PJ
Citation: L. Pendyala et Pj. Creaven, PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF N-ACETYLCYSTEINE, A POTENTIAL CHEMOPREVENTIVE AGENT DURING A PHASE-I TRIAL, Cancer epidemiology, biomarkers & prevention, 4(3), 1995, pp. 245-251

Authors: PENDYALA L CREAVEN PJ PEREZ R ZDANOWICZ JR RAGHAVAN D
Citation: L. Pendyala et al., INTRACELLULAR GLUTATHIONE AND CYTOTOXICITY OF PLATINUM COMPLEXES, Cancer chemotherapy and pharmacology, 36(4), 1995, pp. 271-278

Authors: PENDYALA L KIDANI Y PEREZ R WILKES J BERNACKI RJ CREAVEN PJ
Citation: L. Pendyala et al., CYTOTOXICITY, CELLULAR ACCUMULATION AND DNA-BINDING OF OXALIPLATIN ISOMERS, Cancer letters, 97(2), 1995, pp. 177-184

Authors: MEROPOL NJ PETRELLI NJ RUSTUM YM RODRIQUEZBIGAS M BLUMENSON LE FRANK C BERGHORN E CREAVEN PJ
Citation: Nj. Meropol et al., A PHASE-II AND PHARMACOKINETIC STUDY OF 6S-LEUCOVORIN PLUS 5-FLUOROURACIL IN PATIENTS WITH COLORECTAL-CARCINOMA, Investigational new drugs, 13(2), 1995, pp. 149-155

Authors: MEROPOL NJ CREAVEN PJ PETRELLI NJ
Citation: Nj. Meropol et al., METASTATIC COLORECTAL-CANCER - ADVANCES IN BIOCHEMICAL MODULATION ANDNEW DRUG DEVELOPMENT, Seminars in oncology, 22(5), 1995, pp. 509-524

Authors: MATTHEW AM CHRISTENSSON PI SEIDEGARD J TUVESSON H BIBBY MC HARTLEYASP B CREAVEN PJ
Citation: Am. Matthew et al., EFFECT OF DRUG SCHEDULING ON THE ANTITUMOR-ACTIVITY AND BONE-MARROW TOXICITY OF TAUROMUSTINE (TCNU), International journal of oncology, 4(2), 1994, pp. 403-409

Authors: CREAVEN PJ RUSTUM YM PETRELLI NJ MEROPOL NJ RAGHAVAN D RODRIGUEZBIGAS M LEVINE EG FRANK C UDVARYNAGY S PROEFROCK A
Citation: Pj. Creaven et al., PHASE-I AND PHARMACOKINETIC EVALUATION OF FLOXURIDINE LEUCOVORIN GIVEN ON THE ROSWELL-PARK WEEKLY REGIMEN/, Cancer chemotherapy and pharmacology, 34(3), 1994, pp. 261-265

Authors: PENDYALA L CREAVEN PJ PORTER CW
Citation: L. Pendyala et al., URINARY AND ERYTHROCYTE POLYAMINES DURING THE EVALUATION OF ORAL ALPHA-DIFLUOROMETHYLORNITHINE IN A PHASE-I CHEMOPREVENTION CLINICAL-TRIAL, Cancer epidemiology, biomarkers & prevention, 2(3), 1993, pp. 235-241

Authors: CREAVEN PJ PENDYALA L PETRELLI NJ
Citation: Pj. Creaven et al., EVALUATION OF ALPHA-DIFLUOROMETHYLORNITHINE AS A POTENTIAL CHEMOPREVENTIVE AGENT - TOLERANCE TO DAILY ORAL-ADMINISTRATION IN HUMANS, Cancer epidemiology, biomarkers & prevention, 2(3), 1993, pp. 243-247

Authors: MANZUIK LV PEREVODCHIKOVA NI GORBUNOVA VA SINGIN AS GERASIMOVA GS BYCHKOV MB RUSTUM YM CREAVEN PJ
Citation: Lv. Manzuik et al., INITIAL CLINICAL-EXPERIENCE WITH ORAL FTORAFUR AND ORAL-6R, S-LEUCOVORIN IN ADVANCED COLORECTAL-CARCINOMA, European journal of cancer, 29A(12), 1993, pp. 1793-1794

Authors: COOGAN MM CREAVEN PJ
Citation: Mm. Coogan et Pj. Creaven, ANTIBACTERIAL PROPERTIES OF 8 DENTAL CEMENTS, International endodontic journal, 26(6), 1993, pp. 355-361
Risultati: 1-25 | 26-27